temozolomide
UkraineDrugs containing this active substance
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Form: capsules
Active substance Dosage temozolomide 20 mg ATC: L01AX03
Manufacturer: Eugen Pharma Limited (manufacturing APIs, packaging, testing, batch release)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the event of disease recurrence or progression.
Form: capsules
Active substance Dosage temozolomide 100 mg ATC: L01AX03
Manufacturer: Eugen Pharma Limited (manufacturing APIs, packaging, testing, batch release)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease has recurred or progressed after standard treatment.
Form: capsules
Active substance Dosage temozolomide 180 mg ATC: L01AX03
Manufacturer: Eugen Pharma Limited (manufacturing APIs, packaging, testing, batch release)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (concomitant with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in cases of disease recurrence or progression.
Form: capsules
Active substance Dosage temozolomide 250 mg ATC: L01AX03
Manufacturer: Eugen Pharma Limited (manufacturing APIs, packaging, testing, batch release)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (in the form of glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Form: capsules
Active substance Dosage temozolomide 100 mg ATC: L01AX03
Manufacturer: Orion Pharma (manufacturing, packaging and quality control of unpackaged products; alternative quality control)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Form: powder for solution for infusion
Active substance Dosage temozolomide 100 mg ATC: L01AX03
Manufacturer: Baxter Oncology GmbH (manufacturing of unpackaged products, primary packaging and quality control)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of recurrence or disease progression.
Form: capsules
Active substance Dosage temozolomide 20 mg ATC: L01AX03
Manufacturer: Orion Pharma (manufacturing, packaging and quality control of unpackaged products; alternative quality control)
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Form: capsules
Active substance Dosage temozolomide 5 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or after radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Form: capsules
Active substance Dosage temozolomide 100 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Form: capsules
Active substance Dosage temozolomide 140 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Form: capsules
Active substance Dosage temozolomide 180 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Form: capsules
Active substance Dosage temozolomide 20 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in cases of disease recurrence or progression.
Form: capsules
Active substance Dosage temozolomide 250 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in the event of disease recurrence or progression.
Form: capsules, hard
Active substance Dosage temozolomide 20 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Form: capsules, hard
Active substance Dosage temozolomide 100 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in the event of disease recurrence or progression.
Form: capsules, hard
Active substance Dosage temozolomide 140 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Form: capsules, hard
Active substance Dosage temozolomide 180 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Form: capsules, hard
Active substance Dosage temozolomide 250 mg ATC: L01AX03